Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00773253 · ClinicalTrials.gov registry record · Phase 4
Botox for Cervical Dystonia Following EMG Mapping
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT00773253 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 10 participants.
The verdict
NCT00773253, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how to improve treatment of patients with cervical dystonia who have not been helped with standard Botox injections. This study is for patients with cervical dystonia who have not benefited from treatment with Botox using conventional "single lead electromyographic (EMG) techniques" for injection. The study aim is to see if these patients may have significantly more benefit if their Botox is injected into muscles that have been chosen with a multi-channel EMG mapping study of the neck prior to Botox injection.
Interventions
- DRUG Botulinum toxin A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00773253
The ClinicalTrials.gov registry entry for NCT00773253 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Botulinum toxin A is the first listed.
NCT00773253 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00773253 about?
NCT00773253 is a clinical study titled "Botox for Cervical Dystonia Following EMG Mapping". The purpose of this study is to determine how to improve treatment of patients with cervical dystonia who have not been helped with standard Botox injections. This study is for patients with cervical dystonia who have not benefited from treatment with Botox using conventional "single lead electromyo...
What is the current status of trial NCT00773253?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2008-04. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00773253?
The interventions under investigation include: Botulinum toxin A (DRUG).
Who is sponsoring clinical trial NCT00773253?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.